Skip to main content

CONVERSION OF T-CELL TO MYELOID-LEUKEMIA BY DEOXYCOFORMYCIN (DCF), A POTENT ADENOSINE-DEAMINASE (ADA) INHIBITOR

Publication ,  Journal Article
HERSHFIELD, M; MOORE, J; KURTZBERG, J; HARDEN, E; HAYNES, B
Published in: CLINICAL RESEARCH
January 1, 1983

Duke Scholars

Published In

CLINICAL RESEARCH

ISSN

0009-9279

Publication Date

January 1, 1983

Volume

31

Issue

2

Start / End Page

A508 / A508

Publisher

SLACK INC
 

Citation

APA
Chicago
ICMJE
MLA
NLM
HERSHFIELD, M., MOORE, J., KURTZBERG, J., HARDEN, E., & HAYNES, B. (1983). CONVERSION OF T-CELL TO MYELOID-LEUKEMIA BY DEOXYCOFORMYCIN (DCF), A POTENT ADENOSINE-DEAMINASE (ADA) INHIBITOR. CLINICAL RESEARCH, 31(2), A508–A508.
HERSHFIELD, M., J. MOORE, J. KURTZBERG, E. HARDEN, and B. HAYNES. “CONVERSION OF T-CELL TO MYELOID-LEUKEMIA BY DEOXYCOFORMYCIN (DCF), A POTENT ADENOSINE-DEAMINASE (ADA) INHIBITOR.” CLINICAL RESEARCH 31, no. 2 (January 1, 1983): A508–A508.
HERSHFIELD M, MOORE J, KURTZBERG J, HARDEN E, HAYNES B. CONVERSION OF T-CELL TO MYELOID-LEUKEMIA BY DEOXYCOFORMYCIN (DCF), A POTENT ADENOSINE-DEAMINASE (ADA) INHIBITOR. CLINICAL RESEARCH. 1983 Jan 1;31(2):A508–A508.
HERSHFIELD, M., et al. “CONVERSION OF T-CELL TO MYELOID-LEUKEMIA BY DEOXYCOFORMYCIN (DCF), A POTENT ADENOSINE-DEAMINASE (ADA) INHIBITOR.” CLINICAL RESEARCH, vol. 31, no. 2, SLACK INC, Jan. 1983, pp. A508–A508.
HERSHFIELD M, MOORE J, KURTZBERG J, HARDEN E, HAYNES B. CONVERSION OF T-CELL TO MYELOID-LEUKEMIA BY DEOXYCOFORMYCIN (DCF), A POTENT ADENOSINE-DEAMINASE (ADA) INHIBITOR. CLINICAL RESEARCH. SLACK INC; 1983 Jan 1;31(2):A508–A508.

Published In

CLINICAL RESEARCH

ISSN

0009-9279

Publication Date

January 1, 1983

Volume

31

Issue

2

Start / End Page

A508 / A508

Publisher

SLACK INC